Advanced search
Publication Cover
Scandinavian Journal of Infectious Diseases Volume 20, 1988 - Issue sup57
Submit an article Journal homepage
15
Views
1
CrossRef citations to date
0
Altmetric
Miscellany

Current Trends in the Management of Upper Respiratory Tract Bacterial Infections

Itzhak Brook
&
Carl Erik Nord
Pages 1-64 | Published online: 02 Jan 2015

References

  • Roos K. The diagnostic value of symptoms and signs in acute tonsillitis in children over the age of 10 and in adults. Scand J Infect Dis 17: 259–267, 1985
  • Wannamaker LW. Perplexity and precision in the diagnosis of streptococcal pharyngitis. Am J Dis Child 124: 352–358, 1972
  • Ekedahl C, Holm SE, Roos K. Effective penicillin therapy. Swedish Medical Journal 77: 3866–3867, 1980
  • Benjamin JT, Perriello UA. Pharyngitis due to group C hemolytic streptococci in children. J Pediatr 89: 254–256, 1976
  • Hill HR, Caldwell GG, Wilson E, Hager D, Zimmerman RA. Epidemic of pharyngitis due to streptococci of Lancefield group G. Lancet ii: 371–374, 1969
  • McCue JD. Group G streptococcal pharyngitis. Analysis of an outbreak at a college. JAMA 248: 1333–1356, 1982
  • Schwartz RH, Shulman ST. Group C and G streptococci. In-office isolation from children and adolescents with pharyngitis. Clin Pediatr 25: 496–502, 1986
  • Chretien JH, McGinniss CG, Thompson J, Delaha E, Garagusi VF. Group B beta-hemolytic streptococci causing pharyngitis. J Clin Microbiol 10: 263–266, 1979
  • Woodruff C. Microbiology of infectious diseases of Waldeyer's ring. Ear Nose Throat J 69: 454–456, 1980
  • Teilan SA. Sore throat and antibiotics. Otolaryngol Clin North Am 19: 103–109, 1986
  • Bank G, Nyman M. Tonsillitis and rash associated with Corynebacterium haemolyticum. J Infect Dis 154: 1037–1040, 1986
  • Glezen WP, Clyde WA, Senior RJ, Sheaffer CI, Denny FW. Group A streptococci, mycoplasmas, and viruses associated with acute pharyngitis. JAMA 202: S6, 119–124, 1967
  • Denny FW. Effect of treatment on streptococcal pharyngitis. Pediatr Infect Dis 4: 352–354, 1985
  • Breese B. Epidemiology. In: Breese BB, ed. Beta-hemolytic streptococcal disease. Breese Hall, 48, 1978
  • Roos K, Holm SE, Ekedahl C. Treatment failure in acute streptococcal tonsillitis in children over the age of ten and in adults. Scand J Infect Dis 17: 357–365, 1985
  • Strömberg A, Schwan A, Cars O. Throat carrier rates of beta-hemolytic streptococci among healthy adults and children. Scand J Infect Dis 20: 411–417, 1988
  • Strömberg A, Schwan A. A comparison between a commercial co-agglutination test and conventional throat culture for the detection of group A streptococci in throat swabs. Scand J Infect Dis 18: 85–86, 1986
  • Schwartz RH, Wientzen RL, Pedreira F, Feroli EJ, Mella GW, Guandolo VL. Penicillin V for group A streptococcal pharyngotonsillitis. JAMA 246: 1790–1795, 1981
  • Strömberg A, Schwan A, Cars O. Five versus ten days treatment of group A streptococcal pharyngotonsillitis: A randomized controlled clinical trial with phenoxymethylpenicillin and cefadroxil. Scand J Infect Dis 20: 37–46, 1988
  • Grahn E, Holm SE, Roos K. Penicillin tolerance in beta-streptococci isolated from patients with tonsillitis. Scand J Infect Dis 19: 421–126, 1987
  • Sanders CC, Sanders WE, Harrowe DJ. Bacterial interference: Effects of oral antibiotics on the normal throat flora and its ability to interfere with group A streptococci. Infect Immun 13: 805–812, 1976
  • Nord CE, Heimdahl A, Tunér K. Beta-lactamase producing anaerobic bacteria in the oropharynx and their clinical relevance. Scand J Infect Dis, Suppl. 57: 50–54, 1988
  • Tunér K. Studies on beta-lactamase producing anaerobic bacteria in recurrent tonsillitis and peritonsillitis. Thesis, Karolinska Institute, Stockholm 1986
  • Ginsburg C, McCracken G, Crow S. Erythromycin therapy for group A streptococcal pharyngitis. Am J Dis Child 138: 536–539, 1984

References

  • Wannamaker LW. Differences between streptococcal infections of the throat and of the skin. N Engl J Med 282: 23–30, 78–85, 1970
  • Siegel AC, Johnson EE, Stollerman GH. Controlled studies of streptococcal pharyngitis in a pediatric population. Factors related to the attack rate of rheumatic fever. N Engl J Med 265: 559–565, 1961
  • Bisno AL. Acute rheumatic fever: Current concepts and controversies. In: Remington JS, Swartz MN, eds. Current clinical topics in infectious diseases. New York: McGraw-Hill, 316, 1984
  • Bisno AL. Management of streptococcal infections and prevention of rheumatic fever: The changing scene. In: Sande MA, Hudson LD, Root RK, eds. Respiratory infections: contemporary issues in infectious diseases. New York: Churchill Livingstone, 217, 1986
  • Shulman ST. The decline of rheumatic fever. What impact on our management of pharyngitis. Am J Dis Child 138: 426–427, 1984
  • Glezen WP, Clyde WA Jr, Senior RJ. Group A streptococci, mycoplasmas, and virus associated with acute pharyngitis. JAMA 202: 119–124, 1967
  • Evans AS, Dick EC. Acute pharyngitis and tonsillitis in University of Wisconsin students. JAMA 190: 699–708, 1964
  • Mortimer EA Jr, Walterson RL Jr. A bacteriologic investigation of otitis media in infancy. Pediatrics 17: 159–366, 1956
  • Nelson BW, Poland RL, Thompson RS. Acute otitis media: Treatment results in relation to bacterial etiology. Pediatrics 43: 351–358, 1969
  • Brownlee RC Jr, DeLoache WR, Cowan CC Jr. Otitis media in children: Incidence, treatment and prognosis in pediatric patients. J Pediatr 75: 636–642, 1969
  • Feingold M, Klein JO, Haslam GE Jr. Acute otitis media in children: Bacteriological findings in middle ear fluid obtained by needle aspiration. Am J Dis Child 111: 361–365, 1966
  • Howie VM, Ploussard JH. Bacterial etiology and antimicrobial treatment of exudative otitis media. Relation of antibiotic therapy to relapses. South Med J 64: 233–239, 1971
  • Howie VM, Ploussard JH, Lester RL Jr. Otitis media: A clinical and bacteriological correlation. Pediatrics 45: 29–35, 1970
  • Kamme C, Lundgren K, Mårdh PA. The etiology of acute otitis media in children. Scand J Infect Dis 3: 217–223, 1971
  • Feigin RD, Schackelford PG, Campbell J. Assessment of the role of Staphylococcus epidermidis as a cause of otitis media. Pediatrics 52: 569–576, 1973
  • Henderson FW, Collier AM, Sanyal MA. A longitudinal study of respiratory viruses and bacteria in the etiology of acute otitis media with effusion. N Engl J Med 306: 1377–1383, 1982
  • Feigin RD. Otitis media: Closing the information gap. N Engl J Med 306: 1417–1418, 1982
  • Bluestone CD. Otitis media in children: To treat or not to treat? N Engl J Med 306: 1399–1403, 1982
  • Kenna MA, Bluestone CD. Microbiology of chronic suppurative otitis media in children. Pediatr Infect Dis 5: 223–225, 1986
  • Evans FO, Sydnor JB, Moore WEC. Sinusitis of the maxillary antrum. N Engl J Med 293: 735–739, 1975
  • Hamory BH, Sande MA, Sydnor A Jr. Etiology and antimicrobial therapy of acute maxillary sinusitis. J Infect Dis 139: 197–202, 1979
  • Wald ER, Milmoe GJ, Bowen AD. Acute maxillary sinusitis in children. N Engl J Med 304: 749–754, 1981
  • Healy GB. Acute sinusitis in children. N Engl J Med 304: 779–780, 1981
  • Powers GF, Boisvert GF. Age as a factor in streptococcosis. J Pediatr 25: 481–504, 1944
  • Dajani AS, Garcia RE, Wolinsky E. Etiology of several lymphadenitis in children. N Engl J Med 268: 1329–1333, 1963
  • Barton LL, Feigin RD. Childhood cervical lymphadenitis: A reappraisal. J Pediatr 84: 846–852, 1974
  • Flodström A, Hallander HO. Microbiological aspects of peritonsillar abscesses. Scand J Infect Dis 8: 157–160, 1976
  • Shoemaker M, Lampe RA, Weir MR. Peritonsillitis: Abscess or cellulitis? Pediatr Infect Dis 5: 435–439, 1986
  • Fulginiti VA. Still more on streptococcal pharyngitis: An important disease with yet unresolved clinical issues. JAMA 253: 1302, 1985
  • Nelson JD. The effect of penicillin therapy on the symptoms and signs of streptococcal pharyngitis. Pediatr Infect Dis 3: 10–13, 1984
  • Krober MS, Bass JW, Michels GN. Streptoccoccal pharyngitis: Placebo controlled double-blind evaluation of clinical response to penicillin therapy. JAMA 253: 1271–1274, 1985
  • Gerber MA. Antibiotics and streptococcal throat. Pediatr Infect Dis 10: 23, 1985
  • Breese BB, Disney FA, Talpey WB. Beta-hemolytic streptococcal illness: Comparison of lincomycin, ampicillin, and potassium penicillin G in treatment. Am J Dis Child 112: 21–27, 1966
  • Breese BB, Disney FA, Talpey WB. Beta-hemolytic streptococcal infection: Comparison of penicillin and lincomycin in the treatment of recurrent infections or the carrier state. Am J Dis Child 117: 147–152, 1969
  • Kundsin RB, Miller JM. Significance of the Staphylococcus aureus carrier state in the treatment of disease due to group A streptococci. N Engl J Med 271: 1395–1397, 1964
  • Quie PG, Pierce HC, Wannamaker LW. Influence of penicillinase producing staphylococci on the eradication of group A streptococci from the upper respiratory tract by penicillin treatment. Pediatrics 37: 467–476, 1966
  • Simon HJ, Sukai W. Staphylococcal antagonism to penicillin-G therapy of hemolytic streptococcal pharyngeal infection: Effect of oxacillin. Pediatrics 31: 463–469, 1968
  • Brook I, Yocum P, Shah K. Surface vs. core-tonsillar aerobic and anaerobic flora in recurrent tonsillitis. JAMA 244: 1696–1698, 1980
  • Brook I, Calhoun L, Yocum P. Beta-lactamase-producing isolates of Bacteroides species from children. Antimicrob Agents Chemother 18: 164–166, 1980
  • Brook I, Yocum P. In vitro protection of group A beta-hemolytic streptococci from penicillin and cephalothin by Bacteroides fragilis. Chemotherapy 29: 18–23, 1983
  • Tunér K, Nord CE. Beta-lactamase-producing microorganisms in recurrent tonsillitis. Scand J Infect Dis (Suppl), 39: 83–85, 1983
  • Brook I, Hirokawa R. Treatment of patients with recurrent tonsillitis due to group A beta-hemolytic streptococci: Prospective randomized study comparing penicillin, erythromycin and clindamycin. Clin Pediatr 24: 331–336, 1985
  • Brook I. The role of beta-lactamase-producing bacteria in the persistence of streptococcal tonsillar infection. Rev Infect Dis 6: 601–607, 1984
  • Breese BB. A simple scorecard for the tentative diagnosis of streptococcal pharyngitis. Am J Dis Child 131: 514–517, 1977
  • Crawford C, Brancato F, Holmes KK. Streptococcal pharyngitis: Diagnosis by Gram stain. Ann Intern Med 90: 293–297, 1979
  • Bisno AL, Itzhak O. Serologic diagnosis of streptococcal infection: Comparison of a rapid hemagglutination technique with conventional antibody tests. Am J Dis Child 127: 676–681, 1974
  • Kaplan EL, Huwe BB. The sensitivity and specificity of an agglutination test for antibodies to streptococcal extracellular antigens: A quantitative analysis and comparison of the Streptozyme test with the antistreptolysin O and anti-deoxyribonuclease B tests. J Pediatrics 96: 367–373, 1980
  • Slifkin M, Gil GM. Evaluation of the culturette brand ten minute group A Strep ID technique. J Clin Microb 20: 12–14, 1984
  • Miceika BG, Vitous AS, Thompson KD. Detection of group A streptococcal antigen directly from throat swabs with a ten-minute latex agglutination test. J Clin Microb 21: 467–469, 1985
  • Kim SK, Kaplan EL. Association of penicillin tolerance with failure to eradicate group A streptococci from patients with pharyngitis. J Pediatr 107: 681–684, 1985
  • McDonald CJ, Tierney WM, Hui SL. A controlled trial of erythromycin in adults with non-streptococcal pharyngitis. J Infect Dis 152: 1093–1094, 1985
  • Maruyama S, Yoshioka H, Fujita K. Sensitivity of group A streptococci to antibiotics. Prevalence of resistance to erythromycin in Japan. Am J Dis Child 133: 1143–1145, 1979
  • Miyamoto Y, Takizawa K, Matsushima A. Stepwise acquisition of multiple drug resistance by beta-hemolytic streptococci and difference in resistance pattern by type. Antimicrob Agents Chemother 13: 399–404, 1978
  • Chamovitz R, Rammelkamp CH Jr, Wannamaker LW. The effect of tonsillectomy on the incidence of streptococcal respiratory disease and its complications. Pediatrics 26: 355–367, 1960
  • Feinstein AR, Levitt M. The role of tonsils in predisposing to streptococcal infections and recurrences of rheumatic fever. N Engl J Med 282: 285–291, 1970

References

  • Sugita R, Ichikawa G, Goto S. A bacterial investigation of acute purulent otitis media. Nippon Jibiinkoka Gakkai Kaiho 82: 568–573, 1979
  • Miyake H, Tanaka J. A clinical study on the effect of erythromycin estolate on recent bacterial flora causing acute otitis media. Otolaryngol (Tokyo) 38: 1109–1114, 1966
  • Asano H. Microbes in the otorrhoea and their sensitivity to antibiotics. Otolaryngol (Tokyo) 44: 905–910, 1972
  • Kuriyama K, Masuno H. Studies on the determination of the concentration of antibiotics in humoral and otorrheal fluids. Otolaryngol (Tokyo) 49: 361–364, 1977
  • Kawamura S, Sugita R, Fujimaki Y. A randomized control trial of bacampicillin vs. cephlexin in the treatment of acute purulent otitis media. Pract Otolaryngol (Kyoto) 78: 1147–1165, 1985
  • Sugita R, Kawamura S, Ichikawa G. Chemotherapy of acute purulent otitis media. Nippon Jibiinokoka Gakkai Haiho 82: 1381–1387, 1979
  • Sugita R, Ichikawa G, Goto S. Anaerobic bacteria in otitis media chronica. Pract Otolaryngol (Kyoto) 78: 1166–1170, 1985
  • Hirono YU, Yamamoto E. Bacteria in chronic otitis media and its antimicrobial agent susceptibility. Pract Otolaryngol (Kyoto) 79: 723–728, 1986
  • Osafune H, Nagao M, Nomura T. Microbiological studies of chronic infantile sinusitis. Otolaryngol (Tokyo) 58: 91–98, 1986
  • Ogawa M, Sakai K, Saika H. Tissue concentration and changes of the flora after the administration of lincomycin to the patient with chronic sinusitis. J Jap Soc Infect Dis Otolaryngol 2: 23–26, 1984
  • Baba S. Conservative treatment of tonsillitis. Otolaryngol (Tokyo) 57: 865–869, 1985
  • Sugita R, Kawamura S, Ichikawa G. A bacterial study of peritonsillar abscess and its chemotherapy. Nippon Jibiinkoka Gakkai Kaiho 83: 1036–1041, 1980
  • Fujimaki Y, Kawamura S, Sugita R. Effect of lincomycin hydrochloride in otorhinolaryngological infections. Evaluation of lincomycin in anaerobic infections. Pract Otolaryngol (Kyoto) 78: 1651–1662, 1985
  • Yokoi H, Murahashi K, Yanagita N. Study of tissue concentration of clindamycin-2-phosphate and its clinical usefulness. Pract Otolaryngol (Kyoto) 78: 1171–1180, 1985
  • Brook I, Yocum P, Shah K. Surface vs. core—tonsillar aerobic and anaerobic flora in recurrent tonsillitis. JAMA 244: 1696–1698, 1980
  • Tunér K, Nord CE. Impact of phenoxymethylpenicillin and clindamycin on microflora in recurrent tonsillitis. Ann Otol Rhinol Laryngol 94: 278–280, 1985
  • Sweeny G, Watson JD, McGregor IA. Successful prophylaxis with tinidazole of infection after major head and neck surgery for malignant disease. Br J Plast Surg 37: 35–42, 1984
  • Becker GD, Parell GJ, Busch D. Anaerobic and aerobic bacteriology in head and neck cancer surgery. Trans Am Acad Ophthalmol Otolaryngol 84: 592–602, 1977
  • Seagle MB, Duberstein LE, Gross CW. Efficacy of cefazolin as a prophylactic antibiotic in head and neck surgery. Otorhinolaryngol 86: 568–572, 1978
  • van Laethem Y, Lagast H, Klastersky J. Anaerobic infections in cancer patients—comparison between therapy-oriented strictly against anaerobes or both anaerobes and aerobes. J Antimicrob Chemotherapy 10: 137–144, 1982
  • Mombelli G, Coppens L, Dor P. Antibiotic prophylaxis in surgery for head and neck cancer. Comparative study of short and prolonged administration of carbenicillin. J Antimicrob Chemotherapy 7: 665–671, 1981

References

  • Hardie JM, Bowden GH. The normal flora of the mouth. In: Skinner FA, Carr JG, eds. The normal microbial flora of man. London: Academic Press, 1974
  • van der Hoeven JS. Microbial interactions in the mouth. In: Lehner T, Cimasoni G, eds. The borderland between caries and periodontal disease II. London: Academic Press, 215–226, 1980
  • Nord CE. Anaerobic microorganisms in gingival plaque. In: Lehner T, Cimasoni G (as above), 241–254, 1980
  • van Winkelhoff AJ, van der Velden U, van Steenbergen TJM. Black-pigmented Bacteroides: Pathogens in the oral cavity. Antoine van Leeuwenhoek 51: 599, 1985
  • Socransky SS, Manganiello SD. The oral microbiota of man, from birth to senility. J Periodont 42: 485–494, 1971
  • Socransky SS, Gibbons RJ, Dale AG. The microbiota of the gingival crevice area of man. Total microscopic and viable counts of specific organisms. Arch Oral Biol 8: 275, 1963
  • Hungate RE. The rumen and its microbes. New York: Academic Press, 1966
  • Gordon DF, Stutman M, Loesche WJ. Improved isolation of anaerobic bacteria from gingival crevice area of man. Applied Microbiol 21: 1046, 1971
  • Aranki A, Syed SA, Kenney SB, Freter R. Isolation of anaerobic bacteria from human gingiva and mouse caecum by means of a simplified glove box procedure. Applied Microbiol 17: 568, 1969
  • Loesche WJ. Oxygen sensitivity of various anaerobic bacteria. Applied Microbiol 18: 723, 1969
  • Silverstone LM, Johnson NW, Hardie JM, Williams RAD. Dental caries. Aetiology, pathology and prevention. London: Macmillan, 1981
  • Berg JO, Nord CE. A method for isolation of anaerobic bacteria from endodontic specimens. Scand J Dent Res 81: 163, 1973
  • van Steenbergen TJ, van Winkelhoff AJ, Mayrand D. Bacteroides endodontalis sp. nov. An asaccharolytic black-pigmented Bacteroides species from infected dental root canals. Int J Syst Bacteriol 34: 118–120, 1984
  • Williams BL, McCann GF, Schoenknecht FD. Bacteriology of dental abscesses of endodontic origin. J Clin Microbiol 18: 770–774, 1983
  • Sims W. The clinical bacteriology of purulent oral infections. Br J Oral Surg 12: 1–12, 1974
  • Oguntebi B, Slee AM, Tanzer JM, Langefaud K. Predominant microflora associated with human dental peripheral abscesses. J Clin Microbiol 15: 964–966, 1982
  • Moore WEC, Holdeman LV, Smibert RM. Bacteriology of severe peridontitis in young adult humans. Infect Immun 38: 1137–1148, 1982
  • Slots J, Dahlen G. Subgingival microorganisms and bacterial virulence factors in periodontitis. Scand J Dent Res 93: 119–127, 1984
  • Sundquist GK, Eckerbom MI, Larsson AP. Capacity of anaerobic bacteria from necrotic dental pulps to induce purulent infections. Infect Immun 25: 685–693, 1979
  • Dzink JL, Tanner ACR, Haffajee AD Socransky SS. Gram-negative species associated with active destructive periodontal lesions. J Clin Periodontol 12: 648–649, 1985
  • Sheiham A. An epidemiological survey of acute ulcerative gingivitis in Nigerians. Arch Oral Biol 11: 937, 1966
  • Socransky SS. Relationship of bacteria to the aetiology of periodontal disease. J Dent Res 49: 203, 1970
  • MacDonald JB, Socransky SS, Gibbons RJ. Aspects of the pathogenesis of mixed infections of mucous membranes. J Dent Res 42: 529, 1963
  • Heimdahl A, von Konow L, Satoh T, Nord CE. Clinical appearance of orofacial infections of odontogenic origin in relation to microbiological findings. J Clin Microbiol 22: 299–302, 1985
  • Heimdahl A, Nord CE. Orofacial infections of odontogenic origin. Scand J Infect Dis Suppl 39: 86–91, 1983
  • Heimdahl A, von Konow L, Nord CE. Isolation of beta-lactamase-producing Bacteroides associated with penicillin treatment of human orofacial infections. Arch Oral Biol 25: 689–692, 1980
  • Loesche WJ, Syed SA, Laughon BE. The bacteriology of acute necrotizing ulcerative gingivitis. J Periodont 53: 223–230, 1982
  • Listgarten MA. Electron microscopic observations on the bacterial flora of acute necrotizing ulcerative gingivitis. J Periodont 36: 328, 1965
  • Listgarten MA, Lewis DW. The distribution of spirochaetes in the lesion of acute necrotizing ulcerative gingivitis: An electron microscope and statistical survey. J Periodont 38: 379, 1967
  • Emslie RD. Cancrum oris. Dent Pract 13: 481, 1963
  • Finegold SM. Anaerobic bacteria in human disease. London: Academic Press, 1977
  • Jokipii AMM, Jokipii L. Metronidazole, tinidazole, ornidazole and anaerobic infections of the middle ear, maxillary sinus and central nervous system. Scand J Infect Dis Suppl 26: 123–129, 1981
  • Harker LA, Koontz FP. Bacteriology of cholesteatoma: Clinical significance. Trans Am Acad Ophthalmol Otolaryngol 84: 683, 1977
  • Finegold SM. Central nervous system infections. In: Anaerobic bacteria in human disease. New York: Academic Press, 1977
  • Beerens H, Tahon-Castel M. Infection humaines à bactéries anaérobies non-toxigènes. Bruxelles: Presses Académiques Européennes, p. 92, 1965
  • McFarlan AM. The bacteriology of brain abscess. Br Med J 2: 643, 1983
  • Heineman HS, Braude AI. Anaerobic infection of the brain. Am J Med 35: 682, 1963
  • Alderson D, Strong AJ, Ingham HR. Fifteen year review of the mortality of brain abscess. Neurosurgery 8: 1–6, 1981
  • Yoshikawa TT, Chow AW, Guze LB. Role of anaerobic bacteria in subdural empyema. Report of four cases and review of 327 cases from the English literature. Am J Med 58: 99, 1975
  • Heerema MS, Ein ME, Musher DM, Bradshaw MW. Anaerobic bacterial meningitis. Am J Med 67: 219–227, 1979
  • Stephenson JR, Hopper P, Tabaqchali S. Anaerobic bacterial meningitis. J Infect 13: 37–39, 1986
  • Siegler D, Faiers MC, Willis AT. Bacteroides meningitis complicating chronic mastoiditis. Postgrad Med J 52: 650–651, 1982
  • Bowden GH, Hardie JM. Commensal and pathogenic Actinomyces species in man. In: Sykes G, Skinner FA, eds. Actinomycetales: Characteristics and practical importance. London: Academic Press, 277–299, 1973

References

  • Drasar BS, Hill MJ, eds. Human intestinal flora. London: Academic Press, 1974
  • Hanson LÅ, Brandtzaeg P. The mucosal defence system. In: Stiehm ER, Fulginiti VA, eds. Immunological disorders of infants and children. Philadelphia: WB Saunders, 137–164, 1980
  • Fubara ES, Freter R. Protection against enteric bacterial infection by secretory IgA antibodies. J Immunol 111: 395–403, 1972
  • Engquist S, Lundberg C. Bacteria and inflammatory cells in maxillary sinusitis. Arch Otorhinolaryngol 239: 173–180, 1984
  • Engquist S, Lundberg C, Venge P. Granulocyte proteases in human maxillary sinus secretions. Scand J Infect Dis 15: 119–123, 1983
  • Engquist S, Lundberg C, Venge P. Effects of drainage in the treatment of acute maxillary sinusitis. Acta Otolaryngol (Stockh) 95: 153–159, 1983
  • Nathan DG, Baehner RL. Disorders of phagocytic cell function. Progr Hematol 7: 235–254, 1971
  • von Konow L, Nord CE, Nordenram Å. Anaerobic bacteria in dentoalveolar infections. Int J Oral Surg 10: 313–322, 1981
  • Becker GD, Parell J, Busch DF. Anaerobic and aerobic bacteriology in head and neck cancer surgery. Arch Otolaryngol 104: 591–594, 1978
  • Hallander HO, Flodström A, Holmberg K. Influence of collection and transport of specimens on the recovery of bacteria from peritonsillar abscess. J Clin Microbiol 2: 504–509, 1975
  • Lundberg C, Nord CE, Ramström G. Penicillin treatment in oral surgery in patients with coagulation disorders. Int J Oral Surg 4: 198–204, 1975
  • Fitzgerald DC. Use of prophylactic antibiotics in otologic and neurootologic surgery. Am J Otol 6: 121–125, 1985
  • Herzon FS. The prophylactic use of antibiotics in head and neck surgery. Otolaryngologic Clinics of North America 9: 781–787, 1976
  • Jacobson JA, Kasworm EM. Toxin shock syndrome after nasal surgery. Arch Otolaryngol Head Neck Surg 112: 329–332, 1986
  • Bartzokas CA, Raine CH, Stell PM. Bacteriological assessment of patients undergoing major head and neck surgery. Clin Otolaryngol 9: 99–103, 1984
  • Becker GD. Chemoprophylaxis for surgery of the head and neck. Ann Otorhinolaryngol 84: 8–12, 1981
  • Dor P, Klastersky J. Prophylactic antibiotics in oral, pharyngeal and laryngeal surgery for cancer: (a double-blind study). Laryngoscope 133: 1992–1999, 1973
  • Becker GD, Parell GJ, Busch DF. The non-value of preoperative and intraoperative cultures in predicting the bacteriology of subsequent wound infection in patients undergoing major head and neck cancer surgery. Laryngoscope 90: 1933–1940, 1980

References

  • Scheifele DW, Fussel SJ. Ampicillin-resistant Haemophilus influenzae colonizing ambulatory children. Epidemiology and implications for otitis media therapy. Am J Dis Child 135: 406–409, 1981
  • Kovatch AL, Wald ER, Michaels RH. Beta-lactamase-producing Branhamella catarrhalis causing otitis media in children. J Pediatr 102: 260–263, 1983
  • Murray PR, Rosenblatt JE. Penicillin resistance and penicillinase production in clinical isolates of Bacteroides melaninogenicus. Antimicrob Agents Chemother 11: 605–608, 1977
  • Brook I, Calhoun L, Yocum P. Beta-lactamase-producing isolates of Bacteroides species from children. Antimicrob Agents Chemother 18: 164–166, 1980
  • Brook I, Pettit TH, Martin WJ, Finegold SM. Aerobic and anaerobic bacteriology of acute conjunctivitis. Ann Ophthalmol 11: 13–16, 1978
  • Brook I, Yocum P, Shah K, Feldman B, Epstein S. The aerobic and anaerobic bacteriology of serous otitis media. Am J Otolaryngol 4: 389–392, 1983
  • Brook I, Finegold SM. Bacteriology of chronic otitis media. JAMA 241: 387–388, 1979
  • Brook I. Microbiology of chronic otitis media with perforation in children. Microbiologic studies. Am J Dis Child 134: 564–566, 1980
  • Brook I. Prevalence of beta-lactamase-producing bacteria in chronic suppurative otitis media. Am J Dis Child 139: 280–284, 1985
  • Brook I. Aerobic and anaerobic bacteriology of cholesteatoma. Laryngoscope 91: 250–253, 1981
  • Brook I. Aerobic and anaerobic bacteriology of chronic mastoiditis children. Am J Dis Child 135: 478–479, 1981
  • Brook I. Bacteriologic features of chronic sinusitis in children. JAMA 246: 967–969, 1981
  • Brook I. Aerobic and anaerobic bacteriology of adenoids in children: A comparison between patients with chronic adenotonsillitis and adenoid hypertrophy. Laryngoscope 91: 377–382, 1981
  • Brook I, Yocum P, Friedman EM. Aerobic and anaerobic bacteria in tonsils of children with recurrent tonsillitis. Ann Otol Rhinol Laryngol 90: 261–263, 1981
  • Brook I, Yocum P. Bacteriology of chronic tonsillitis in young adults. Arch Otolaryngol 110: 883–805, 1984
  • Brook I. Aerobic and anaerobic bacteriology of peritonsillar abscess in children. Acta Paediatr Scand 70: 831–835, 1981
  • Brook I. Microbiology of retropharyngeal abscesses in children. Am J Dis Child 141: 202–205, 1987
  • Brook I, Finegold SM. Bacteriology of aspiration pneumonia in children. Pediatrics 65: 1115–1120, 1980
  • Brook I, Finegold SM. Bacteriology and therapy of lung abscess in children. J Pediatr 94: 10–12, 1979
  • Brook I. Bacterial colonization, tracheobronchitis, and pneumonia following tracheostomy and long-term intubation in pediatric patients. Chest 76: 420–424, 1979
  • Brook I, Fink R. Transtracheal aspiration in pulmonary infection in children with cystic fibrosis. Eur J Respir Dis 64: 51–57, 1983
  • Hackman AS, Wilkins TD. In vivo protection of Fusobacterium necrophorum from penicillin by Bacteroides fragilis. Antimicrob Agents Chemother 7: 698–703, 1975
  • Brook I, Puzzaglia G, Coolbaugh JC, Walker RI. In vitro protection of group A beta-hemolytic streptococci by beta-lactamase-producing Bacteroides species. J Antimicrob Chemother 29: 18–23, 1983
  • Simon HM, Sakai W. Staphylococcal antagonism to penicillin group therapy of hemolytic streptococcal pharyngeal infection: Effect of oxacillin. Pediatrics 31: 463–469, 1963
  • Scheifele DW, Fussel SJ. Frequency of ampicillin resistant Haemophilus parainfluenzae in children. J Infect Dis 143: 495–498, 1981
  • Brook I, Yocum P. In vitro protection of group A beta-hemolytic streptococci from penicillin and cephalothin by Bacteroides fragilis. Chemother 29: 18–23, 1983
  • DeLouvis J, Hurley R. Inactivation of penicillin by purulent exudates. Br Med J 2: 998–1000, 1977
  • Masuda G, Tomioka S. Possible beta-lactamase activities detectable in infective clinical specimens. J Antibiot (Tokyo) 30: 1093–1097, 1977
  • O'Keefe JP, Tally FP, Barza M, Gorbach SL. Inactivation of penicillin G during experimental infection with Bacteroides fragilis. J Infect Dis 137: 437–442, 1979
  • Bryant RE, Rashad AL, Mazza JA, Hammond D. Beta-lactamase activity in human pus. J Infect Dis 143: 594–601, 1980
  • Boughton WH. Rapid detection in spinal fluid of beta-lactamase produced by ampicillin-resistant Haemophilus influenzae. J Clin Microbiol 15: 1167–1668, 1982
  • Yolken RH, Hughes WT. Rapid diagnosis of infections caused by beta-lactamase-producing bacteria by means of an enzyme radioisotopic assay. J Pediatr 97: 715–720, 1980
  • Brook I. Presence of beta-lactamase-producing bacteria and beta-lactamase activity in abscesses. Am J Clin Pathol 86: 97–100, 1986
  • Heimdahl A, von Konow L, Nord CE. Isolation of beta-lactamase-producing Bacteroides strains associated with clinical failures with penicillin treatment of human orofacial infections. Arch Oral Biol 25: 288–292, 1980
  • Brook I. Beta-lactamase-producing bacteria recovered after clinical failures with various penicillin therapy. Arch Otolaryngol 110: 228–231, 1984
  • Gastanaduy AS, Kaplan EL, Huwe BB, McKay C, Wannamaker LW. Failure of penicillin to eradicate group A streptococci during an outbreak of pharyngitis. Lancet 2: 498–502, 1980
  • Knudsin RB, Miller JM. Significance of the Staphylococcus aureus carrier state in the treatment of disease due to group A streptococci. New Engl J Med 271: 1395–1397, 1964
  • Quie PG, Pierce AX, Wannamaker LW. Influence of penicillinase producing staphylococci on the eradication of group A streptococci from the upper respiratory tract by penicillin treatment. Pediatrics 37: 467–476, 1966
  • Brook I, Hirokawa R. Treatment of patients with a history of recurrent tonsillitis due to group A beta-hemolytic streptococci. Clin Pediatr 24: 331–336, 1985
  • Brook I, Yocum P. Quantitative measurement of beta-lactamase levels in tonsils of children with recurrent tonsillitis. Acta Otolaryngol Scand 98: 446–460, 1984
  • Reilly S, Imms P, Beeden AG, Willis AT. Possible role of the anaerobes in tonsillitis. J Clin Pathol 34: 542–547, 1981
  • Chagollan JJR, Macias JR, Gil JS. Flora indigena de las amigdalas. Investigacion Medica Internacional 11: 36–38, 1984
  • Tunér K, Nord CE. Beta-lactamase-producing microorganisms in recurrent tonsillitis. Scand J Infect Dis Suppl 39: 83–85, 1983
  • Tunér K, Lindqvist L, Nord CE. Purification and properties of a novel beta-lactamase from Fusobacterium nucleatum. Antimicrob Agents Chemother 27: 943–947, 1985
  • Brook I, Gober AE. Emergence of beta-lactamase-producing aerobic and anaerobic bacteria in the oropharynx of children following penicillin chemotherapy. Clin Pediatrics 23: 338–341, 1984
  • Tunér K, Nord CE. Emergence of beta-lactamase-producing microorganisms in the tonsils during penicillin treatment. Eur J Clin Microbiol 5: 399–404, 1986
  • Brook I. Emergence and persistence of beta-lactamase-producing bacteria in the oropharynx following penicillin treatment. Arch Otolaryngol 114: 667–670, 1988
  • Brook I. Role of beta-lactamase-producing bacteria in penicillin failure to eradicate group A streptococci. Pediatric Infect Dis 4: 491–495, 1985
  • Roos K, Grahn E, Holm SE. Evaluation of betalactamase activity and microbial interference in treatment failures of acute streptococcal tonsillitis. Scand J Infect Dis 18: 313–319, 1986
  • Breese BB, Disney FA, Talpey WB. Beta-hemolytic streptococcal illness: Comparison of lincomycin, ampicillin and potassium penicillin G in treatment. Am J Dis Child 112: 21–7, 1966
  • Breese BB, Disney FA, Talpey WB, Green J. Beta-hemolytic streptococcal infection: Comparison of penicillin and lincomycin in the treatment of recurrent infections or the carrier state. Am J Dis Child 117: 147–54, 1969
  • Randolph MF, DeHaan RM. A comparison of lincomycin and penicillin in the treatment of group A streptococcal infections: Speculation on the “L” forms as a mechanism of recurrence. Del Med J 41: 51–62, 1969
  • Howie VM, Plousard JH. Treatment of group A streptococcal pharyngitis in children: Comparison of lincomycin and penicillin G given orally and benzathine penicillin G given intramuscularly. Am J Dis Child 121: 477–480, 1971
  • Randolph MF, Redys JJ, Hibbard EW. Streptococcal pharyngitis III. Streptococcal recurrence rates following therapy with penicillin or with clindamycin (7-chlorlincomycin). Del Med J 42: 87–92, 1970
  • Stillerman M, Isenberg HD, Facklan RR. Streptococcal pharyngitis therapy: Comparison of clindamycin palmitate and potassium phenoxymethylpenicillin. Antimicrob Agents Chemother 4: 516–520, 1973
  • Massel BF. Prophylaxis of streptococcal infection and rheumatic fever: A comparison of orally administered clindamycin and penicillin. JAMA 241: 1589–1594, 1979
  • Brook I, Leyva F. The treatment of the carrier state of group A beta-hemolytic streptococci with clindamycin. Chemotherapy 27: 360–367, 1981
  • Levison ME, Magura CT, Lober B, Abnithyn E, Pesanti EL, Levy RS, MacGregor RR, Schwartz AR. Clindamycin compared with penicillin for the treatment of anaerobic lung abscesses. Ann Int Med 98: 466–471, 1983

References

  • Nord CE, Heimdahl A, Lundberg C. Anaerobic infections in the upper respiratory tract. Drugs Clin Exptl Res 3: 155–160, 1984
  • Edson RS, Rosenblatt JV, Lee DT, McVey EC. III. Recent experience with antimicrobial susceptibility of anaerobic bacteria. Increasing resistance to penicillin. Mayo Clin Proc 57: 737–741, 1982
  • Nord CE. Mechanisms of beta-lactam resistance in anaerobic bacteria. Rev Infect Dis 8: S543–S548, 1986
  • Heimdahl A, von Konow L, Nord CE. Beta-lactamase-producing Bacteroides species in the oral cavity in relation to penicillin therapy. J Antimicrob Chemother 8: 225–229, 1981
  • Tunér K, Nord CE. Beta-lactamase-producing microorganisms in recurrent tonsillitis. Scand J Infect Dis 39: 83–85, 1983
  • Nord CE, Olsson-Liljequist B. Resistance to beta-lactam antibiotics in Bacteroides species. J Antimicrob Chemother 8: 33–42, 1981
  • Sherrill JM, McCarthy R. Further studies of the beta-lactamases of Bacteroides species. Current Microbiol 11: 231–234, 1984
  • Tunér K, Lindqvist L, Nord CE. Purification and properties of a novel beta-lactamase from Fusobacterium nucleatum. Antimicrob Agents Chemother 27:, 943–947, 1985
  • Timewell R, Phillips I, Söderholm J, Nord CE. Isoelectric focusing of Bacteroides melaninogenicus group beta-lactamases. Antimicrob Agents Chemother 19: 700–704, 1981
  • Heimdahl A, von Konow L, Nord CE. Clinical appearance of orofacial infections of odontogenic origin in relation to microbial findings. J Clin Microbiol 22: 299–302, 1985
  • Heimdahl A, von Konow L, Nord CE. Isolation of beta-lactamase-producing Bacteroides strains associated with penicillin treatment of human orofacial infections. Arch Oral Biol 25: 689–692, 1980
  • Heimdahl A, von Konow L, Nord CE. Clinical significance of penicillin-resistant beta-lactamase-producing Bacteroides species in human orofacial infections. In: Ullman U, ed. Betalactamasen. Stuttgart: Gustav Fischer Verlag, 49–56, 1984
  • Lundberg C, Heimdahl A, Nord CE. Clindamycin in the upper respiratory tract infections. Scand J Infect Dis 43: 50–55, 1984
  • Heimdahl A, Nord CE. Treatment of orofacial infections of odontogenic origin. Scand J Infect Dis 46: 101–105, 1985
  • Flodström A, Hallander HO. Microbiological aspects on peritonsillar abscesses. Scand J Infect Dis 8: 157–160, 1976
  • Tunér K, Nord CE. Impact on peritonsillar infections and microflora of phenoxymethylpenicillin alone versus phenoxymethylpenicillin in combination with metronidazole. Infection 14: 129–133, 1986
  • Tunér K, Nord CE. Emergence of beta-lactamase producing microorganisms in the tonsils during penicsllin treatment. Eur J Clin Microbiol 5: 399–404, 1986
  • Brook I, Freidman E, Yocum P. Aerobic and anaerobic bacteria in tonsils of children with recurrent tonsillitis. Ann Otolaryngol 90: 261–263, 1981
  • Tunér K, Nord CE. Impact of phenoxymethylpenicillin and clindamycin on microflora in recurrent tonsillitis. Ann Otolaryngol 94: 278–280, 1985
  • Brook I, Yocum P. In vitro protection of group A beta-hemolytic streptococci from penicillin by Bacteroides fragilis. Chemother 29: 18–23, 1983
  • Brook I, Pazzaglia G, Coolbaugh JC, Walker RI. In vivo protection of group A beta-hemolytic streptococci from penicillin by beta-lactamase producing Bacteroides species. J Antimicrob Chemother 12: 599–606, 1983
  • Sutherland R. Indirect pathogenicity of beta-lactamase and the role of beta-lactamase inhibitors. Presented at the 14th International Congress of Chemotherapy, Kyoto, 1985, Abstract WS-22-4.
  • Randolph MF, Redys JJ, Hibbard EW. Streptococcal pharyngitis. Part III. Streptococcal recurrence rates following therapy with penicillin or with clindamycin. Del Med J 41: 87–92, 1970

References

  • Chow AW, Roser SM, Brady FA. Orofacial odontogenic infections. Ann Intern Med 88: 392–402, 1978
  • Haapasalo M, Ranta H, Ranta K, Shah H. Black-pigmented Bacteroides spp. in human apical periodontitis. Infect Immun 53: 149–153, 1986
  • Sundqvist G. Bacterial studies of necrotic pulps, Umeå University Odontological Dissertations no. 7, Umå, Sweden, 1976, University of Umeå
  • Griffee MB, Patterson SS, Miller CH, Kafrawy KH, Newton CW. The relationship of Bacteroides melaninogenicus to symptoms associated with pulpal necrosis. Oral Surg 50: 457–461, 1980
  • Hackman AS, Wilkins TD. Influence of penicillinase production by strains of Bacteroides melaninogenicus and Bacteroides oralis on penicillin therapy of an experimental mixed anaerobic infection in mice. Archs Oral Biol 21: 385–389, 1976
  • Heimdahl A, von Konow L, Nord CE. Isolation of β-lactamase-producing Bacteroides strains associated with clinical failures with penicillin treatment of human orofacial infections. Archs Oral Biol 25: 689–692, 1980
  • Gorbach SL, Bartlett JG. Anaerobic infections. N Engl J Med 290: 1177–1184, 1237–2354, 1289–1294, 1974
  • Thadepalli H, Gorbach SL, Broido PW, Norsen J, Nyhus L. Abdominal trauma, anaerobes, and antibiotics. Surg Gynecol Obstet 137: 270–276, 1973
  • Yee MH, Guiney DG, Hasegawa P, Davis CE. The clinical significance of clindamycin-resistant Bacteroides fragilis. JAMA 248: 1860–1863, 1982
  • Tally FP, Shimell MJ, Malamy MH. Antimicrobial resistance and resistance transfer in anaerobic bacteria. First United States Metronidazole Symposium. In: Finegold SM, ed. New York: BMI Publishers, 43–53, 1982
  • Oguntebi B, Slee AM, Tanzer JM, Langeland K. Predominant microflora associated with human dental periapical abscesses. J Clin Microbiol 15: 964–966, 1982
  • Sabiston CB, Grigsby WR, Segerstrom N. Bacterial study of pyogenic infections of dental origin. Oral Surg 41: 430–434, 1976
  • Aderhold L, Knothe H, Grenkel G. The bacteriology of dentogenous pyogenic infections. Oral Surg 52: 583–587, 1981
  • Murray PR, Rosenblatt JE. Penicillin resistance and penicillinase production in clinical isolates of Bacteroides melaninogenicus. Antimicrob Agents Chemother 11: 605–608, 1977
  • Laatsch LJ, Hohenfeldt PR, Kos WL. Antibiotic susceptibility of black-pigmented Bacteroides isolates from the human oral cavity. Antimicrob Agents Chemother 22: 687–700, 1982
  • Goldstein EJC, Citron DM, Vagvolgyi AE, Finegold SM. Susceptibility of bite wound bacteria to seven oral antimicrobial agents, including RU-985, a new erythromycin: Considerations in choosing empiric therapy. Antimicrob Agents Chemother 29: 556–559, 1986
  • Garrod LP. Sensitivity of four species of Bacteroides to antibiotics. Br Med J 2: 1529–1531, 1955
  • Tally FP, Cuchural GJ, Jacobus NY, Gorbach SL, Aldridge KE, Cleary TJ, Finegold SM, Hill GB, Iannini PB, McCloskey RV, O'Keefe JP, Pierson CL. Nationwide study of the susceptibility of the Bacteroides fragilis group in the United States. Antimicrob Agents Chemother 28: 675–677, 1985
  • Sosa A, Tally FP, Jacobus NV, Gorbach SL. Bacteroides fragilis resistance to clindamycin in vitro. Antimicrob Agents Chemother 22: 771–774, 1982
  • Cuchural GJ, Tally FP, Jacobus NV, Marsch PK, Mayhew JW. Cefoxitin inactivation by Bacteroides fragilis. Antimicrob Agents Chemother 24: 936–940, 1983
  • Cuchural GJ, Malamy MH, Tally FP. β-Lactamase-mediated imipenem resistance in Bacteroides fragilis. Antimicrob Agents Chemother 30: 645–648, 1986
  • Martinez-Suarez JV, Baquero F, Reig M, Perez-Diaz JC. Transferable plasmid-linked chloramphenicol acetyltransferase conferring high-level resistance in Bacteroides uniformis. Antimicrob Agents Chemother 28: 113–117, 1985
  • Pinkus G, Veto G, Braude AI. Bacteroides penicillinase. J Bacteriol 96: 1437–1440, 1968
  • Anderson JD, Sykes RB. Characterisation of a β-lactamase obtained from a strain of Bacteroides fragilis resistant to β-lactamase antibiotics. J Med Microbiol 6: 201–206, 1973
  • Darland C, Birnbaum J. Cefoxitin resistance to beta-lactamase. A major factor for susceptibility of Bacteroides fragilis to the antibiotic. Antimicrob Agents Chemother 9: 727–735, 1975
  • Olsson B, Nord CE, Wadström T. Formation of beta-lactamase in Bacteroides fragilis: Cell-bound and extracellular activity. Antimicrob Agents Chemother 9: 727–735, 1976
  • Tally FP, O'Keefe JP, Sullivan NM, Gorbach SL. Inactivation of cephalosporins by Bacteroides. Antimicrob Agents Chemother 16: 565–571, 1979
  • Britz ML, Wilkinson RG. Purification and properties of beta-lactamase from Bacteroides fragilis. Antimicrob Agents Chemother 13: 373–382, 1978
  • Sato K, Matsuura Y, Miyata K, Inoue M, Mitsuhashi S. Characterization of cephalosporinases from Bacteroides fragilis. Bacteroides thetaiotaomicron and Bacteroides vulgatus. J Antibiotics XXXVI: 76–85, 1983
  • Olsson-Liljequist B, Dornbusch K, Nord CE. Characterization of three different β-lactamases from the Bacteroides fragilis. Antimicrob Agents Chemother 18: 220–225, 1980
  • Sato K, Matsuura Y, Inoue M, Mitsuhashi S. Properties of a new penicillinase type produced by Bacteroides fragilis. Antimicrob Agents Chemother 22: 579–584, 1982
  • Yotsuji A, Minami S, Inoue M, Mitsuhashi S. Properties of novel β-lactamase produced by Bacteroides fragilis. Antimicrob Agents Chemother 24: 925–929, 1983
  • Cuchural GJ, Hurlbut S, Tally FP. Imipenem resistance in Bacteroides distasonis mediated by a novel beta-lactamase. Abstract 511. Presented at the 26th Interscience Conference on Antimicrobial Agents and Chemotherapy, New Orleans, 1986
  • Timewell RM, Phillips I, Söderholm J, Nord CE. Isoelectric focusing of Bacteroides melaninogenicus group β-lactamases. Antimicrob Agents Chemother 19: 700–704, 1981
  • Olsson B, Dornbusch K, Nord CE. Factors contributing to resistance to beta-lactam antibiotics in Bacteroides fragilis. Antimicrob Agents Chemother 15: 263–268, 1979
  • Piddock LJV, Wise R. Cefoxitin resistance in Bacteroides species: Evidence indicating two mechanisms causing decreased susceptibility. J Antimicrob Chemother 19: 161–170, 1987
  • Butler T, Tally FP, Gorbach SL, Malamy MH. Transferable ampicillin resistance in Bacteroides fragilis. Clin Res 28: 365 (abstract), 1980
  • Cuchural GJ, Tally FP, Storey JR, Malamy MH. Transfer of β-lactamase-associated cefoxitin resistance in Bacteroides fragilis. Antimicrob Agents Chemother 29: 918–920, 1986
  • Reig M, Campello MG, Baquero F. Epidemiology of clindamycin resistance in the Bacteroides fragilis group. J Antimicrob Chemother 14: 595–603, 1984
  • Kesado T, Watanabe K, Asahi Y, Isono M, Ueno K. Susceptibilities of anaerobic bacteria to N-for-mimidoyl Thienamycin (MK0787) and to other antibiotics. Antimicrob Agents Chemother 21: 1016–1022, 1982
  • Lai CJ, Weisblum B. Altered methylation of ribosomal RNA in an erythromycin-resistant strain of Staphylococcus aureus. Proc Natl Acad Sci USA 68: 856–860, 1971
  • Weisblum B, Holder SB, Halling SM. Deoxyribonucleic acid sequence common to staphylococcal and streptococcal plasmids which specify erythromycin resistance. J Bacteriol 138: 990–998, 1979
  • Novick RP, Edelman I, Schwesinger MD, Gruss AD, Swanson EC, Pattee PA. Genetic translocation in Staphylococcus aureus. Proc Natl Acad Sci USA 76: 400–404, 1979
  • Tally FP, Cuchural GJ, Bieluch VM, Jacobus NV, Malamy MH. Clindamycin resistance in anaerobic bacteria. Scand J Infect Dis 43: ( Suppl) 34–43, 1984
  • Privitera G, Dublanchet A, Sebald M. Transfer of multiple antibiotic resistance between subspecies of Bacteroides fragilis. J Infect Dis 139: 97–101, 1979
  • Tally FP, Sosa A, Jacobus NV, Malamy MH. Clindamycin resistance in Bacteroides fragilis. J Antimicrob Chemother 8: ( Suppl D) 43–48, 1981
  • Rasmussen JL, Odelson DA, Macrina FL. Complete nucleotide sequence and transcription of ermF, a macrolide-lincosamide-streptogramin B resistance determinant from Bacteroides fragilis. J Bacteriol 168: 523–533, 1986
  • Welch RA, Jones KR, Macrina FL. Plasmid-mediated transfer of lincosamide-macrolide-and-tetra-cycline resistance in Bacteroides. Plasmid 2: 261–268, 1979
  • Tally FP, Snydman DR, Gorbach SL, Malamy MH. Plasmid-mediated transferable resistance to clindamycin and erythromycin in Bacteroides fragilis. J Inf Dis 139: 85–88, 1979
  • Smith CJ, Macrina FL. Large transmissible clindamycin resistance plasmid in Bacteroides ovatus. J Bacteriol 158: 739–741, 1984
  • Robillard NJ, Tally FP, Malamy MH. Tn4400: A compound transposon isolated from Bacteroides fragilis, functions in Escherichia coli. J Bacteriol 164: 1248–1255, 1985
  • Shoemaker NB, Guthrie EP, Salyers AA, Gardner JF. Evidence that the clindamycin-erythromycin resistance gene of Bacteroides plasmid pBF4 is on a transposable element. J Bacteriol 162: 626–632, 1985
  • Marsch PK, Malamy MH, Shimell MJ, Tally FP. Sequence homology of clindamycin resistance determinants in clinical isolates of Bacteroides spp. Antimicrob Agents Chemother 23: 726–730, 1983
  • Shimell MJ, Smith CJ, Tally FP, Macrina FL, Malamy MH. Hybridization studies reveal homologies between pBF4 and pBFTM10, two clindamycin-erythromycin resistance transfer plasmids of Bacteroides fragilis. J Bacteriol 152: 950–953, 1982
  • McMurry L, Levy SB. Two transport systems for tetracycline in sensitive Escherichia coli: Critical role for an initial rapid uptake system insensitive to energy inhibitors. Antimicrob Agents Chemother 14: 201–209, 1978
  • Levy SB, McMurry L. Plasmid-determined tetracycline resistance involves new transport system for tetracycline. Nature 276: 90–92, 1978
  • Fayolle F, Privitera G, Sebald M. Tetracycline transport in Bacteroides fragilis. Antimicrob Agents Chemother 18: 502–505, 1980
  • Privitera G, Fayolle F, Sebald M. Resistance to tetracycline, erythromycin, and clindamycin in the Bacteroides fragilis group: Inducible versus constitutive tetracycline resistance. Antimicrob Agents Chemother 20: 314–320, 1981
  • Malamy MH, Tally FP. Mechanisms of drug resistance transfer in Bacteroides fragilis. J Antimicrob Chemother 8: ( Suppl D) 59–75, 1981
  • Franke AE, Clewell DB. Evidence for a chromosome borne resistance transposon (Tn916) in Streptococcus faecalis that is capable of “conjugal” transfer in the absence of a conjugative plasmid. J Bacteriol 145: 494–502, 1981
  • Louie TJ, Bartlett JC, Onderdonk AB, Gorbach SL. Failure of chloramphenicol therapy of experimental intraabdominal abscess. Abstract 25. Presented at the 17th Interscience Conference on Antimicrobial Agents and Chemotherapy, Chicago, 1977
  • Britz ML, Wilkinson RG. Chloramphenicol acetyltransferase of Bacteroides fragilis. Antimicrob Agents Chemother 14: 105–111, 1978
  • Ingham HR, Eaton S, Venables CW, Adams PC. Bacteroides fragilis resistant to metronidazole after long term therapy. Lancet 1: 214, 1978
  • Tally FP, Snydman DR, Shimell MJ, Goldin BR. Mechanisms of antimicrobial resistance of Bacteroides fragilis. In: Phillips I, Collier J, eds. Metronidazole: Proceedings of the 2nd International Symposium on Anaerobic Infections. London: Academic Press, 19–27, 1979
  • Keenholtz SL, Tally FP, Goldin BR, Malamy MH. Isolation and characterization of a metronid-azole-resistant mutant of Bacteroides fragilis. Abstract 766. Presented at the 21st Interscience Conference on Antimicrobial Agents and Chemotherapy, Chicago, 1981
  • Bryant LE, van den Elizen HM. Streptomycin accumulation in susceptible and resistant strains of Escherichia coli and Pseudomonas aeruginosa. Antimicrob Agents Chemother 9: 928–938, 1976

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.